Liver Dysfunction
Type 2 diabetes is a condition in which pancreatic islet β-cells, which are responsible for producing insulin to lower blood glucose levels, experience a decline in insulin production capacity, leading to elevated blood sugar levels.
This treatment aims to improve diabetic symptoms by intravenously administering stem cells (adipose-derived stem cells) collected from the patient’s own fat tissue, thereby promoting the recovery of pancreatic β-cell function and suppressing inflammation associated with diabetes.
This therapy is intended for patients with type 2 diabetes or borderline diabetes (prediabetes). Stem cells are isolated from the patient’s own fat tissue and cultured until the required number of cells is reached, after which they are administered via intravenous infusion.